Skip to main content
Have a personal or library account? Click to login
Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis Cover

Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis

Revista Romana de Medicina de Laborator
Volume 24 (2016): Issue 2 (June 2016)
By: Cătălin Codreanu,  Corina Mogoșan,  Claudiu Costinel Popescu,  Simona Rednic,  Horațiu Popovici,  Magda Pârvu,  Daniela Opriș and  Ruxandra Ionescu  
Open Access
|Jun 2016
Metrics

Metrics

DOI: https://doi.org/10.1515/rrlm-2016-0018 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Journal RSS Feed
Language: English
Page range: 212 - 222
Submitted on: Oct 15, 2015
Accepted on: Apr 3, 2016
Published on: Jun 28, 2016
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
rheumatoid arthritis;antinuclear antibodies;biological therapy
Related subjects:
Life sciences,
Molecular biology,
Biochemistry,
Human biology,
Microbiology and virology

© 2016 Cătălin Codreanu, Corina Mogoșan, Claudiu Costinel Popescu, Simona Rednic, Horațiu Popovici, Magda Pârvu, Daniela Opriș, Ruxandra Ionescu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 24 (2016): Issue 2 (June 2016)
Previous article
Next article